Clin Colon Rectal Surg 2006; 19(4): 237-246
DOI: 10.1055/s-2006-956446
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Postoperative Enterocutaneous Fistula: When to Reoperate and How to Succeed

Kathryn L. Galie1 , Charles B. Whitlow2
  • 1West County Surgical Specialists, Inc., St. Louis, Missouri
  • 2Department of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, Louisiana
Further Information

Publication History

Publication Date:
24 November 2006 (online)

ABSTRACT

An enterocutaneous fistula (ECF) is a potentially catastrophic postoperative complication. Although the morbidity and mortality associated with ECF have decreased over the past 50 years with modern medical and surgical care, the overall mortality is still surprisingly high, up to 39% in recent literature. It seems prudent, then, for every surgeon to have a thorough grasp of optimal treatment strategies for ECF to minimize their patients' mortality. Ultimately, the algorithm must begin with prevention. Once an ECF is diagnosed, the first step is to resuscitate and treat sepsis. The second is to control fistula output. The third step is to optimize the patient medically and nutritionally. The last step is definitive restoration of gastrointestinal continuity when necessary. Special mention is given in this article to exceptionally refractory fistulas such as those arising in the presence of inflammatory bowel disease and irradiated bowel. This plan gives a framework for the difficult task of successfully treating the postoperative ECF with a multidisciplinary approach.

REFERENCES

  • 1 Cameron J. Current Surgical Therapy. 7th ed. St. Louis, MO; Mosby 2001: 156-161
  • 2 Haffejee A A. Surgical management of high output enterocutaneous fistulae: a 24-year experience.  Curr Opin Clin Nutr Metab Care. 2004;  7 309-316
  • 3 Alvarez C, McFadden D W, Reber H A. Complicated enterocutaneous fistulas: failure of octreotide to improve healing.  World J Surg. 2000;  24 533-538
  • 4 Makhdoom Z A, Komar M J, Still C D. Nutrition and enterocutaneous fistulas.  J Clin Gastroenterol. 2000;  31 195-204
  • 5 Campos A C, Andrade D F, Campos G M, Matias J E, Coelho J C. A multivariate model to determine prognostic factors in gastrointestinal fistulas.  J Am Coll Surg. 1999;  188 483-490
  • 6 Memon A S, Siddiqui F G. Causes and management of postoperative enterocutaneous fistulas.  J Coll Physicians Surg Pak. 2004;  14 25-28
  • 7 Berry S M, Fischer J E. Classification and pathophysiology of enterocutaneous fistulas.  Surg Clin North Am. 1996;  76 1009-1018
  • 8 Sinha S K, Sethy P K, Kaman L et al.. Multiple spontaneous enterocutaneous fistulae in malakoplakia.  Indian J Gastroenterol. 2003;  22 234-235
  • 9 Evenson A R, Fischer J E. Current management of enterocutaneous fistula.  J Gastrointest Surg. 2006;  10 455-464
  • 10 Lynch A C, Delaney C P, Senagore A J, Connor J T, Remzi F H, Fazio V W. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery.  Ann Surg. 2004;  240 825-831
  • 11 Chambers W M, Mortensen N J. Postoperative leakage and abscess formation after colorectal surgery.  Best Pract Res Clin Gastroenterol. 2004;  18 865-880
  • 12 D'Harcour J B, Boverie J H, Dondelinger R F. Percutaneous management of enterocutaneous fistulas.  AJR Am J Roentgenol. 1996;  167 33-38
  • 13 Kaur N, Minocha V R, Mundu M. Improving outcome in patients of high output small bowel fistula.  Trop Gastroenterol. 2004;  25 92-95
  • 14 Kaushal M, Carlson G L. Management of enterocutaneous fistulas.  Clin Colon Rectal Surg. 2004;  17 79-88
  • 15 Goverman J, Yelon J A, Platz J J, Singson R C, Turcinovic M. The “fistula VAC” a technique for management of enterocutaneous fistulae arising within the open abdomen: report of 5 cases.  J Trauma. 2006;  60 428-431
  • 16 Nienhuijs S W, Manupassa R, Strobbe L J, Rosman C. Can topical negative pressure be used to control complex enterocutaneous fistulae?.  J Wound Care. 2003;  12 343-345
  • 17 Cro C, George K J, Donnelly J, Irwin S T, Gardiner K R. Vacuum assisted closure system in the management of enterocutaneous fistulae.  Postgrad Med J. 2002;  78 364-365
  • 18 Medeiros A C, Aires-Neto T, Marchini J S, Brandao-Neto J, Valenca D M, Egito E S. Treatment of postoperative enterocutaneous fistulas by high-pressure vacuum with a normal oral diet.  Dig Surg. 2004;  21 401-405
  • 19 Wang X B, Ren J A, Li J S. Sequential changes of body composition in patients with enterocutaneous fistula during the 10 days after admission.  World J Gastroenterol. 2002;  8 1149-1152
  • 20 Evans J P, Steinhart A H, Cohen Z, McLeod R S. Home total parenteral nutrition: an alternative to early surgery for complicated inflammatory bowel disease.  J Gastrointest Surg. 2003;  7 562-566
  • 21 Lloyd D A, Powell-Tuck J. Artificial nutrition: principles and practice of enteral feeding.  Clin Colon Rectal Surg. 2004;  17 107-118
  • 22 Teubner A, Morrison K, Ravishankar H R, Anderson I D, Scott N A, Carlson G L. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula.  Br J Surg. 2004;  91 625-631
  • 23 Mettu S R. Correspondence: fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula (Br J Surg 2004;91:625-631).  Br J Surg. 2004;  91 1203
  • 24 Arebi M, Forbes A. High-output fistula.  Clin Colon Rectal Surg. 2004;  17 89-98
  • 25 Jamil M, Ahmed U, Sobia H. Role of somatostatin analogues in the management of enterocutaneous fistulae.  J Coll Physicians Surg Pak. 2004;  14 237-240
  • 26 Torres A J, Landa J I, Moreno-Azcoita M et al.. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial.  Arch Surg. 1992;  127 97-99
  • 27 Hesse U, Ysebaert D, Hemptinne B. Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data.  Gut. 2001;  49(Suppl IV) iv11-iv20
  • 28 González-Pinto I, González E M. Optimising the treatment of upper gastrointestinal fistulae.  Gut. 2001;  49(Suppl IV) iv22-iv31
  • 29 Maconi G, Parente F, Porro G B. Hydrogen peroxide enhanced ultrasound- fistulography in the assessment of enterocutaneous fistulas complicating Crohn's disease.  Gut. 1999;  45 874-878
  • 30 Regueiro M. The role of endoscopy in the evaluation of fistulizing Crohn's disease.  Gastrointest Endosc Clin N Am. 2002;  12 621-633
  • 31 Eleftheriadis E, Kotzampassi K. Therapeutic fistuloscopy: an alternative approach in the management of postoperative fistulas.  Dig Surg. 2002;  19 230-236
  • 32 Rabago L R, Ventosa N, Castro J L, Marco J, Herrera N, Gea F. Endoscopic treatment of postoperative fistulas resistant to conservative management using biological fibrin glue.  Endoscopy. 2002;  34 632-638
  • 33 Dalton D, Woods S. Successful endoscopic treatment of enterocutaneous fistulas by histoacryl glue.  Aust NZ J Surg. 2000;  70 749-750
  • 34 Johnson E K, Gaw J U, Armstrong D N. Efficacy of anal fistula plug vs. fibrin glue in closure of anorectal fistulas.  Dis Colon Rectum. 2006;  49 371-376
  • 35 Schultz D J, Brasel K J, Spinelli K S, Rasmussen J, Weigelt J A. Porcine small intestine submucosa as a treatment for enterocutaneous fistulas.  J Am Coll Surg. 2002;  194 541-543
  • 36 Hollington P, Mawdsley J, Lim W, Gabe S M, Forbes A, Windsor A J. An 11-year experience of enterocutaneous fistula.  Br J Surg. 2004;  91 1646-1651
  • 37 Zografos G C, Peros G, Androulakis G. Palliative surgical treatment in enterocutaneous fistula.  J Surg Oncol. 1997;  66 138
  • 38 Poritz L S, Gagliano G A, McLeod R S, MacRae H, Cohen Z. Surgical management of entero and colocutaneous fistulae in Crohn's disease: 17 year's experience.  Int J Colorectal Dis. 2004;  19 481-485
  • 39 Present D H, Rutgeerts P, Targan S et al.. Infliximab for the treatment of fistulas in patients with Crohn's disease.  N Engl J Med. 1999;  340 1398-1405
  • 40 Sands B E, Anderson F H, Bernstein C N et al.. Infliximab maintenance therapy for fistulizing Crohn's disease.  N Engl J Med. 2004;  350 876-885
  • 41 Poritz L S, Rowe W A, Koltun W A. Remicade does not abolish the need for surgery in fistulizing Crohn's disease.  Dis Colon Rectum. 2002;  45 771-775
  • 42 Date R S, Panesar K J, Neilly P. Infliximab as a therapy for non-Crohn's enterocutaneous fistulae.  Int J Colorectal Dis. 2004;  19 603-606
  • 43 Chamberlain R S, Kaufman H L, Danforth D N. Enterocutaneous fistula in cancer patients: etiology, management, outcome, and impact on further treatment.  Am Surg. 1998;  64 1204-1211
  • 44 Chintamani , Badran R, Rk D, Singhal V, Bhatnagar D. Spontaneous enterocutaneous fistula 27 years following radiotherapy in a patient of carcinoma penis.  World J Surg Oncol. 2003;  1 23
  • 45 Regimbeau J M, Panis Y, Gouzi J L, Fagniez P L. French University Association for Surgical Research . Operative and long term results after surgery for chronic radiation enteritis.  Am J Surg. 2001;  182 237-242
  • 46 Russell J C, Welch J P. Operative management of radiation injuries of the intestinal tract.  Am J Surg. 1979;  137 433-442
  • 47 Lui R C, Friedman R, Fleischer A. Management of postirradiation recurrent enterocutaneous fistula by muscle flaps.  Am Surg. 1989;  55 403-407

Kathryn L GalieM.D. 

West County Surgical Specialists, Inc.

621 South New Ballas Rd., Ste. 7011B, St. Louis, MO 63141

Email: klgalie@yahoo.com

    >